Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: Morphologic and cytogenetic characteristics

American Journal of Clinical Pathology

Volumn 133, Issue 1, 2010, Pages 92-100

  Cioc, Adina M ^a   Wagner, John E ^a   MacMillan, Margaret L ^a   DeFor, Todd ^a   Hirsch, Betsy ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Chromosome; Clone; Cytogenetics; Dyserythropoiesis; Dysgranulopoiesis; Dysmegakaryopoiesis; Fanconi; Hematopathology; Myelodysplastic syndrome

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME 1Q; CHROMOSOME 3Q; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CONTROLLED STUDY; CYTOGENETICS; DYSERYTHROPOIESIS; FANCONI ANEMIA; FEMALE; HUMAN; HUMAN TISSUE; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; SCHOOL CHILD;

ADOLESCENT; ADULT; ANEUPLOIDY; BONE MARROW CELLS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, 1-3; CHROMOSOMES, HUMAN, PAIR 7; CLONE CELLS; COHORT STUDIES; FANCONI ANEMIA; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MYELODYSPLASTIC SYNDROMES; YOUNG ADULT;

EID: 73949143725     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCP7W9VMJENZOVG     Document Type: Article

References (24)

1. Ameziane N, Errami A, Leveille F, et al. Genetic subtyping of Fanconi anemia by comprehensive mutation screening. Hum Mutat. 2008;29:159-166.
2. Bagby GC, Alter BP. Fanconi anemia. Semin Hematol. 2006;43:147-156.
3. Alter BP. Diagnosis, genetics, and management of inherited bone marrow failure syndromes. Hematology Am Soc Hematol Educ Program. 2007:29-39.
4. Bagby GC, Lipton JM, Sloand EM, et al. Marrow failure. Hematology Am Soc Hematol Educ Program. 2004:318-336.
5. Auerbach AD, Allen RG. Leukemia and preleukemia in Fanconi anemia patients: a review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogenet. 1991;51:1-12.
6. Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer. 2003;97:425-440.
7. Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood. 2003;101:1249-1256.
8. Alter BP, Caruso JP, Drachtman RA, et al. Fanconi anemia: myelodysplasia as a predictor of outcome. Cancer Genet Cytogenet. 2000;117:125-131.
9. Owen J, Frohnmayer L, Eiler ME. Fanconi Anemia: Standards for Clinical Care. 2nd ed. Eugene, OR: Fanconi Anemia Research Fund; 2003.
10. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008. WHO Classification of Tumours; vol 2.
11. Cantu Rajnoldi A, Fenu S, Kerndrup G, et al. Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS). Ann Hematol. 2005;84:429-433.
12. Berger R, Bernheim A, Le Coniat M, et al. Chromosomal studies of leukemic and preleukemic Fanconi's anemia patients: examples of acquired "chromosomal amplification." Hum Genet. 1980;56:59-62.
13. Berger R, Jonveaux P. Clonal chromosome abnormalities in Fanconi anemia. Hematol Cell Ther. 1996;38:291-296.
14. Maarek O, Jonveaux P, Le Coniat M, et al. Fanconi anemia and bone marrow clonal chromosome abnormalities. Leukemia. 1996;10:1700-1704.
15. Alter BP, Scalise A, McCombs J, et al. Clonal chromosomal abnormalities in Fanconi's anaemia: what do they really mean? Br J Haematol. 1993;85:627-630.
16. Tonnies H, Huber S, Kuhl JS, et al. Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor. Blood. 2003;101:3872-3874.
17. Hartsock RJ, Smith EB, Petty CS. Normal variations with aging of the amount of hematopoietic tissue in bone marrow from the anterior iliac crest: a study made from 177 cases of sudden death examined by necropsy. Am J Clin Pathol. 1965;43:326-331.
18. Shaffer LG, Tommerup N, eds. ISCN 2005: An International System for Human Cytogenetic Nomenclature (2005). Basel, Switzerland: Karger; 2005.
19. Hasle H, Niemeyer CM, Chessells JM, et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia. 2003;17:277-282.
20. Niemeyer CM, Baumann I. Myelodysplastic syndrome in children and adolescents. Semin Hematol. 2008;45:60-70.
21. Guinan EC, Shimamura A. Acquired and inherited aplastic anemia syndromes. In: Greer JP, Foerster J, Lukens JN, eds. Wintrobe's Clinical Hematology. Vol 1. 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003:1409-1412.
22. Elghetany MT. Myelodysplastic syndromes in children: a critical review of issues in the diagnosis and classification of 887 cases from 13 published series. Arch Pathol Lab Med. 2007;131:1110-1116.
23. Faivre L, Guardiola P, Lewis C, et al; for the European Fanconi Anemia Research Group. Association of complementation group and mutation type with clinical outcome in Fanconi anemia. Blood. 2000;96:4064-4070.
24. Meyer S, Fergusson WD, Whetton AD, et al. Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia - derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption. Genes Chromosomes Cancer. 2007;46:359-372.